Assembly Biosciences Chief Legal and Business Officer Jason Okazaki receives $3.9M in 2020

Assembly Biosciences reports 2020 executive compensation

By ExecPay News

Published: April 7, 2021

Assembly Biosciences reported fiscal year 2020 executive compensation information on April 7, 2021.
In 2020, five executives at Assembly Biosciences received on average a compensation package of $2.4M, a 23% decrease compared to previous year.
Average pay of disclosed executives at Assembly Biosciences
Jason A. Okazaki, Chief Legal and Business Officer, received $3.9M in total. 63% of Okazaki's compensation, or $2.4M, was in option awards. Okazaki also received $100K in bonus, $209K in non-equity incentive plan, $394K in salary, as well as $753K in stock awards.
John G. McHutchison, A.O., Chief Executive Officer, received a compensation package of $3.2M, which decreased by 54% compared to previous year. 32% of the compensation package, or $1M, was in option awards.
William E. Delaney IV, Chief Scientific Officer, earned $2.7M in 2020.
Thomas J. Russo, Chief Financial Officer, received $1.2M in 2020, which decreases by 42% compared to 2019.
Jacqueline S. Papkoff, Chief Scientific Officer, earned $994K in 2020, a 28% decrease compared to previous year.

Related executives

John AO

Assembly Biosciences

Chief Executive Officer

Thomas Russo

Assembly Biosciences

Chief Financial Officer

Jason Okazaki

Assembly Biosciences

Chief Operating Officer

William Delaney

Assembly Biosciences

Chief Scientific Officer

Jacqueline Papkoff

Assembly Biosciences

Chief Scientific Officer

You may also like

Source: SEC filing on April 7, 2021.